These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 18202218

  • 1. Iatrogenic Creutzfeldt-Jakob disease 22 years after human growth hormone therapy: clinical and radiological features.
    Furtner M, Gelpi E, Kiechl S, Knoflach M, Zangerl A, Gotwald T, Willeit J, Maier H, Ströbel T, Unterberger U, Budka H.
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):229-31. PubMed ID: 18202218
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Iatrogenic Creutzfeld-Jakob disease. Significance of cases observed after extracted growth hormone treatment].
    Billette de Villemeur T.
    Rev Neurol (Paris); 1998 Oct; 154(10):651-2. PubMed ID: 9846334
    [No Abstract] [Full Text] [Related]

  • 4. A further British case of growth hormone induced Creutzfeldt-Jakob disease.
    Ellis CJ, Katifi H, Weller RO.
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1200-2. PubMed ID: 1479400
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging.
    Lewis AM, Yu M, DeArmond SJ, Dillon WP, Miller BL, Geschwind MD.
    Arch Neurol; 2006 Feb; 63(2):288-90. PubMed ID: 16476821
    [Abstract] [Full Text] [Related]

  • 7. Chorea as a presenting feature of variant Creutzfeldt-Jakob disease.
    McKee D, Talbot P.
    Mov Disord; 2003 Jul; 18(7):837-8. PubMed ID: 12815669
    [Abstract] [Full Text] [Related]

  • 8. [Iatrogenic Creutzfeldt-Jakob disease. Lessons from cases secondary to extracted growth hormone in France].
    Billette de Villemeur T, Pradel A.
    Transfus Clin Biol; 1994 Jul; 1(5):333-7. PubMed ID: 7812459
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A nationwide cohort study on Creutzfeldt-Jakob disease among human growth hormone recipients.
    Wientjens DP, Rikken B, Wit JM, Hofman A, Stricker BH.
    Neuroepidemiology; 2000 Jul; 19(4):201-5. PubMed ID: 10859499
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood.
    Holmes SJ, Ironside JW, Shalet SM.
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):333-5. PubMed ID: 8609514
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neuropathology of iatrogenic Creutzfeldt-Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology.
    Duyckaerts C, Sazdovitch V, Ando K, Seilhean D, Privat N, Yilmaz Z, Peckeu L, Amar E, Comoy E, Maceski A, Lehmann S, Brion JP, Brandel JP, Haïk S.
    Acta Neuropathol; 2018 Feb; 135(2):201-212. PubMed ID: 29209767
    [Abstract] [Full Text] [Related]

  • 18. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.
    Noguchi-Shinohara M, Hamaguchi T, Kitamoto T, Sato T, Nakamura Y, Mizusawa H, Yamada M.
    Neurology; 2007 Jul 24; 69(4):360-7. PubMed ID: 17646628
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.